Welsh Carson Anderson & Stowe has secured a significant exit milestone after Lumexa Imaging raised $463m in its US IPO, Reuters reports. 

Lumexa priced the offering within its target range, achieving a multi-billion-dollar valuation. The company operates in the medical imaging space, a sector that has attracted sustained private equity interest.

The listing provides partial liquidity for Welsh Carson, which backed Lumexa during its expansion phase. The IPO comes as sponsors increasingly test equity markets after a prolonged slowdown in exits.

Healthcare remains a core focus for private equity firms seeking defensive growth and scalable platforms.

Lumexa’s debut highlights how select assets are again finding receptive public investors.

If you think we missed any important news, please do not hesitate to contact us at [email protected].

Can`t stop reading? Read more.